Literature DB >> 17031283

Avastin and new treatments for AMD: where are we?

William R Freeman, Iryna Falkenstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031283     DOI: 10.1097/01.iae.0000244722.35073.7c

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  9 in total

Review 1.  Age-related macular degeneration.

Authors:  Tariq Ayoub; Nishal Patel
Journal:  J R Soc Med       Date:  2009-02       Impact factor: 5.344

2.  The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results.

Authors:  Francesca Mojana; Lingyun Cheng; Dirk-Uwe G Bartsch; Gabriel A Silva; Igor Kozak; Nitin Nigam; William R Freeman
Journal:  Am J Ophthalmol       Date:  2008-06-06       Impact factor: 5.258

3.  Age-related macular degeneration: what do patients find on the internet?

Authors:  Christina A Rennie; Shabeeba Hannan; Nick Maycock; Chee Kang
Journal:  J R Soc Med       Date:  2007-10       Impact factor: 5.344

4.  Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

Authors:  N Nigam; J Hedaya; W R Freeman
Journal:  Br J Ophthalmol       Date:  2008-06       Impact factor: 4.638

Review 5.  Porous silicon in drug delivery devices and materials.

Authors:  Emily J Anglin; Lingyun Cheng; William R Freeman; Michael J Sailor
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

6.  [Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].

Authors:  D Kook; A Wolf; A S Neubauer; C Haritoglou; S G Priglinger; A Kampik; M W Ulbig
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

7.  Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186.

Authors:  Iryna A Falkenstein; Lingyun Cheng; Flossie Wong-Staal; Ajay M Tammewar; Erin C Barron; Gabriel A Silva; Qi-Xiang Li; Dehua Yu; Michelle Hysell; Guohong Liu; Ning Ke; James E Macdonald; William R Freeman
Journal:  Curr Eye Res       Date:  2008-07       Impact factor: 2.424

8.  Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration.

Authors:  Mehdi Modarreszadeh; Masood Naseripour; Khalil Ghasemi-Falavarjani; Aminollah Nikeghbali; Masih Hashemi; Mohammad-Mehdi Parvaresh
Journal:  J Ophthalmic Vis Res       Date:  2008-04

9.  Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration.

Authors:  Mohammad Riazi-Esfahani; Hamid Ahmadieh; Hooshang Faghihi; Niloofar Piri; Ramin Taei; Reza Karkhaneh; Zahra Alami-Harandi; Alireza Lashay; Ahmad Mirshahi; Mehdi Nili-Ahmadabadi; Masoud Soheilian; Masoumeh Sanagou
Journal:  J Ophthalmic Vis Res       Date:  2008-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.